CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Résumé de cet Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Additional Material
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Habib, A. S.
Right arrow Articles by Gan, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Habib, A. S.
Right arrow Articles by Gan, T. J.
Canadian Journal of Anesthesia 51:311-319 (2004)
© Canadian Anesthesiologists' Society, 2004
General Anesthesia

The efficacy of the 5-HT3 receptor antagonists combined with droperidol for PONV prophylaxis is similar to their combination with dexamethasone. A meta-analysis of randomized controlled trials

[L’efficacité de la combinaison des antagonistes des récepteurs 5-HT3 et du dropéridol ou de la dexamé- thasone est similaire pour prévenir les NVPO. Une méta-analyse d’essais randomisés et contrôlés]

Ashraf S. Habib, MBBCH MSC FRCA, Habib E. El-Moalem, PhD and Tong J. Gan, MBBS FRCA FFARCS (I)

From the Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina, USA.

Address correspondence to: Dr. Tong J. Gan, Department of Anesthesiology, Box 3094, Duke University Medical Center, Durham, North Carolina 27710, USA. Phone: 919-681-4660; Fax: 919-681-7901; E-mail: Gan00001{at}mc.duke.edu

Purpose: The aim of this quantitative systematic review is to compare the efficacy and side effects of combining one of the 5-HT3 receptor antagonists (5-HT) with droperidol or dexamethasone for postoperative nausea and vomiting (PONV) prophylaxis.

Methods: We performed a systematic search (Medline, Embase, and the Cochrane Library) for randomized controlled trials that compared the antiemetic efficacy of combining one of the 5-HT with droperidol or dexamethasone vs 5-HT alone. Relevant endpoints were prevention of early (0 to 6 hr), and overall (0 to 24 hr) PONV, and side effects. The articles that could meet the inclusion criteria were scored for inclusion and methodological validity using the three-item, five-point, Oxford-scale. Relative risk and numbers needed-to-treat with 95% confidence intervals were calculated for each combination vs 5-HT alone. The two combinations were then indirectly compared. A random effects model was used.

Results: We considered 41 trials for analysis but subsequently excluded eight. Thirty-three trials with data from 3,447 patients were analyzed. Except for early nausea with the 5-HT plus droperidol, both combinations were significantly more effective than 5-HT in preventing early and overall PONV. There was no difference in antiemetic efficacy between the two combinations. The incidence of commonly reported side effects was also similar in the two combination groups.

Conclusion: We conclude that there is no statistically significant difference in antiemetic efficacy or side effects profile when one of the 5-HT is combined with either droperidol or dexamethasone and that both combination regimens are significantly more effective than 5-HT alone.




This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
A. S. Habib and T. J. Gan
Haloperidol for Postoperative Nausea and Vomiting: Are We Reinventing the Wheel?
Anesth. Analg., May 1, 2008; 106(5): 1343 - 1345.
[Full Text] [PDF]

Home page
 Anesth. Analg.Home page
A. S. Habib and T. J. Gan
PRO: The Food and Drug Administration Black Box Warning on Droperidol Is Not Justified
Anesth. Analg., May 1, 2008; 106(5): 1414 - 1417.
[Full Text] [PDF]

Home page
 Anesth. Analg.Home page
T. J. Gan, T. A. Meyer, C. C. Apfel, F. Chung, P. J. Davis, A. S. Habib, V. D. Hooper, A. L. Kovac, P. Kranke, P. Myles, et al.
Society for Ambulatory Anesthesia Guidelines for the Management of Postoperative Nausea and Vomiting
Anesth. Analg., December 1, 2007; 105(6): 1615 - 1628.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
M. T. V. Chan, K. C. Choi, T. Gin, P. T. Chui, T. G. Short, P. M. Yuen, A. H. Y. Poon, C. C. Apfel, and T. J. Gan
The Additive Interactions Between Ondansetron and Droperidol for Preventing Postoperative Nausea and Vomiting
Anesth. Analg., November 1, 2006; 103(5): 1155 - 1162.
[Abstract] [Full Text] [PDF]

Home page
 Canadian J. AnesthesiaHome page
M. R. Tramer
Rational control of PONV - the rule of three/Le controle rationnel des NVPO - la regle de trois
Can J Anesth, April 1, 2004; 51(4): 283 - 285.
[Full Text] [PDF]

Home page
 Canadian J. AnesthesiaHome page
A. S. Habib and T. J. Gan
Evidence-based management of postoperative nausea and vomiting: a review: [Le traitement des nausees et des vomissements postoperatoires fonde sur des donnees probantes : une revue]
Can J Anesth, April 1, 2004; 51(4): 326 - 341.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Canadian Anesthesiologists' Society.